Connect with us

Technology

IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights

Published

on

MELBOURNE, Australia and ZURICH, Dec. 6, 2024 /PRNewswire/ — Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns to support the standardisation of its research services platforms and enable deeper, reproducible proteome profiling.  

Following extensive consultation with the Biognosys team, IonOpticks has developed a custom chromatography column, which is tailored to Biognosys’ needs and is available exclusively for use in their TrueDiscovery®, TrueSignature®, and TrueTarget® contract research services.

Consistent with IonOpticks’ dedication to high-quality, tailored solutions, the custom column integrates seamlessly into Biognosys’ workflows, addressing the company’s unwavering criteria for chromatography that maximises sensitivity, depth of coverage and reproducibility in the context of their broader platform.

“Collaborating with the world-class team at Biognosys has been an incredibly rewarding experience. Developing a column that stands up to their rigorous performance and quality standards has been an exciting project, aligning well with our broader ambition to continue delivering the best performing columns to meet the expanding needs of the market,” says Xavier Perronnet, CEO of IonOpticks.

“This partnership is consistent with our mission to work with the best, to develop columns that enable users to push the boundaries of proteomics research, whilst making LC-MS workflows for proteomics more accessible. Biognosys’ services are outstanding, and their offerings are extremely valuable to a diverse client base.  We’re delighted to be contributing our expertise in chromatography to their overall offering,” Perronnet continues.

“At Biognosys, our priority is to provide the best research services available to a broad array of biotech and pharma customers, requiring scrutiny of every aspect of our platforms to ensure they operate at their peak. Chromatographic performance, the separation of biological analytes prior to detection, is a critical factor for the success of LC-MS workflows and directly impacts discovery outcomes. We were keen to collaborate with the IonOpticks team to develop a chromatography column specifically tailored to our specific requirements, and they delivered,” says Lukas Reiter, Ph.D., Chief Technology Officer at Biognosys.

IonOpticks and Biognosys are proud to collaborate and set new benchmarks in LC-MS-based research, reaffirming their commitment to delivering high-performance solutions that drive innovation and shape the future of proteomics.

— ENDS —

About IonOpticks
IonOpticks produces high-performance chromatography solutions for the global research community enhancing mass spectrometry (LC-MS) and high-end proteomics research. Their solutions enhance the sensitivity of mass spectrometry sample analysis, enabling scientists and clinicians to discover more from their samples. These advancements are valuable for a broad range of applications within the field of biological and medical research including drug discovery, phosphoproteomics and shotgun proteomics.

https://ionopticks.com/

About Biognosys 

At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery®, TrueTarget®, and TrueSignature® research service platforms, our flagship software Spectronaut®, and the PQ500™ kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible.

For more information, visit biognosys.com.

 

View original content:https://www.prnewswire.com/apac/news-releases/ionopticks-custom-chromatography-column-to-become-biognosys-standard-for-high-quality-proteomic-insights-302323523.html

SOURCE IonOpticks

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MoonPay Invests in Korean Fintech Pioneer Finger, Laying Groundwork for a Korean Won Stablecoin Ecosystem

Published

on

By

The landmark ~$76M deal alongside Sungho Electronics and Pantos Holdings aims to connect MoonPay’s global crypto payments infrastructure with Finger’s domestic financial software network.

NEW YORK, April 22, 2026 /PRNewswire/ — MoonPay, the leading crypto payments network, KOSDAQ-listed Sungho Electronics, and its controlling shareholder Seoryong Electronics have signed an agreement to jointly invest in Finger, one of Korea’s first-generation fintech companies, in a deal that lays the foundation for a Korean won stablecoin ecosystem, from issuance to real-world usage.

Founded in 2000, Finger is a pioneering Korean fintech company whose technology powers the mobile banking apps used by tens of millions of Koreans daily. Its clients include Shinhan Bank, KB Kookmin Bank, KakaoBank, NongHyup Bank, and IBK Industrial Bank, among others. Its flagship service, “Full Banking,” is a financial platform solution covering account inquiry, transfers, payments, asset management, integrated account aggregation, and simple payment services. Its client base also includes public institutions such as the National Pension Service and the Korea Minting and Security Printing Corporation. Last year, the company recorded annual revenue of KRW 91.6 billion and operating profit of KRW 1.4 billion.

The approximately KRW 110 billion (~$76M) deal, also includes Pantos Holdings, a strategic investor wholly owned by Koo Bon-ho, a member of the LG founding family and former major shareholder of LX Pantos, the logistics arm of LX Group. The deal will combine MoonPay’s stablecoin issuance and orchestration infrastructure with Finger’s domestic financial software network, while linking Finger’s cloud ERP solution, “Pharos,” with MoonPay’s payments rails to commercialize stablecoin-based settlement for corporate trade payments.

Following the transaction, Seoryong Electronics will become Finger’s largest shareholder. Park Min-soo, the current vice chairman and controlling shareholder, will remain a key shareholder and serve in an advisory role to management.

Seoryong Electronics is the controlling shareholder of Sungho Electronics, with CEO Park Sung-jae holding a 100% stake in Seoryong Electronics. As Sungho Electronics has been focusing on business diversification through M&A, Seoryong Electronics has now also stepped forward directly to secure new growth engines through acquisitions.

Lee Bugeon, Founding Executive and Head of Asia at MoonPay, commented, “This investment opens the way to combine MoonPay’s stablecoin issuance and orchestration infrastructure with Finger’s domestic financial software network. It marks an important foothold for building the full infrastructure needed to support a Korean won stablecoin ecosystem, from issuance to real-world usage.”

Park Sung-jae, CEO of Sungho Electronics, said, “We will support the development of next-generation digital financial services for corporations by connecting ERP-based financial accounting data with payment infrastructure.”

About MoonPay
Founded in 2019, MoonPay is a global financial technology company that helps businesses and consumers move value across fiat and digital assets. MoonPay has more than 30 million customers across 180 countries and supports more than 500 enterprise customers spanning crypto and fintech.

MoonPay powers ramps, trading, commerce, and stablecoin infrastructure, connecting traditional payment rails with blockchains. MoonPay maintains a broad regulatory footprint, including a New York BitLicense, a New York Limited Purpose Trust Charter, and money transmitter licenses across the United States, as well as MiCA authorization in the EU.

MoonPay is how the world moves value.

For media enquiries, contact:
press@moonpay.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/moonpay-invests-in-korean-fintech-pioneer-finger-laying-groundwork-for-a-korean-won-stablecoin-ecosystem-302750964.html

SOURCE MoonPay

Continue Reading

Technology

Strong results achieved in world-first Graphene enhanced cement roof tile trial

Published

on

By

Highlights

Production trial of graphene enhanced roof tiles with FP McCann achieves CO2 reduction of up to 14%Project conducted in the United Kingdom also showed 26% reduction in CEM I-to-concrete ratio required to produce concrete roof tilesGraphene enhanced roof tiles to be used in new buildings at FP McCann’s Cadeby siteSuccessful results pave the way to enter US$7.6 billion[1] global cement roof tile market

SYDNEY, April 22, 2026 /PRNewswire/ — First Graphene Limited (ASX: FGR; “First Graphene” or “the Company”) (FRA:M11) (OTCQB:FGPHF) is pleased to announce results from a world-first production trial of graphene enhanced roof tiles with the UK’s largest precast concrete manufacturer and supplier FP McCann.

The five-month project used 40 tonnes of PureGRAPH® enhanced cement, developed by First Graphene’s partner Breedon Group, to produce more than 10,000 tiles at FP McCann’s Cadeby manufacturing facility in the UK.

The final graphene enhanced cement roof tiles were tested for quality, efficiency and carbon emission reduction potential, as well as performance consistency.

The production process achieved a cradle-to-gate reduction in carbon emissions of up to 14%, reinforcing the lower-carbon benefits of graphene for cement. The required amount of cement for the tiles was also reduced by up to 8%.

Importantly, the trial confirmed graphene enhanced cement, classified as CEM-II, could produce the same roof tiles at the same strength with fewer materials and lower costs compared to CEM-I.  

The tiles will be distributed for use in a variety of projects, including installation on a new building at FP McCann’s Cadeby site.

Conversations have commenced with industry partners following receipt of the results to determine interest in the graphene enhanced roof tiles for projects across the United Kingdom.

The UK Government has also committed to deliver more than one million affordable and sustainable new homes in the next three years and has been funding innovative construction solutions to achieve this goal.

This project was supported via ‘Contracts for Innovation’ with the UK Department for Energy Security and Net Zero (DESNZ) and the ‘Resource Efficient Construction Impacts’ program by the UK Department for Environment, Food and Rural Affairs’ (DEFRA).

The trial solidifies First Graphene’s entrance into the global cement roof tile market which is anticipated to grow to US$11.8 billion by 2034[1].

First Graphene Managing Director and CEO, Michael Bell, said:

“The results of this inaugural trial of graphene-enhanced cement roof tiles with FP McCann has reaffirmed the viability and performance benefits of a lower-emission cement product for the construction industry.

Reducing the amount of cement required by up to 20% has a significant impact on the carbon footprint of these roof tiles, paving the way for more sustainable houses and buildings.

As industry and governments look for innovative solutions to develop lower-carbon infrastructure, First Graphene and FP McCann, in partnership with Breedon Group, have a tested production blueprint to achieve emission reduction goals while maintaining or exceeding material performance capability.”

References

[1]Industry Research

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/strong-results-achieved-in-world-first-graphene-enhanced-cement-roof-tile-trial-302750112.html

SOURCE First Graphene Limited

Continue Reading

Technology

AKEEYO to Showcase 710 & 730 Series Cycling Cameras at Cycle Mode Tokyo 2026

Published

on

By

Full Lineup of Next-Generation Bike Cameras Available for Live Demo at East Hall 7, Booth 7-514

SHENZHEN, China, April 23, 2026 /PRNewswire/ — AKEEYO will exhibit at Cycle Mode Tokyo 2026 (April 25–26, Tokyo Big Sight, Booth 7-514 / East Hall 7), showcasing four cycling cameras with live demonstrations.

Exhibition Details

Event

Cycle Mode Tokyo 2026

Dates & Hours

Saturday, April 25, 2026: 10:00 – 18:00

Sunday, April 26, 2026: 10:00 – 17:00

Venue

Tokyo Big Sight, East Hall 7

Booth Number

7-514

Products on Display

AKY-730Pro  |  Flagship Bike Camera  |  US$200
Powered by an 8MP Sony IMX678 sensor (1/1.8″ Full @ 60FPS) with F/1.7 ultra-large aperture, 4K resolution, built-in GPS, 1.14″ touchscreen, EIS stabilization, IP66 waterproofing, and a 3300mAh battery delivering up to 6 hours of recording.

AKY-710Pro  |  Pro-Grade 8MP Bike Camera  |  US$139.99
Equipped with an 8MP GC8613 sensor (1/2.7″ Full @ 60FPS), F/1.6 aperture, 4K video, EIS gyro stabilization, dual-band Wi-Fi (2.4G/5G), and IP66 waterproofing. Built for demanding cyclists.

AKY-710S  |  Value Champion  |  US$99.99
5MP Sony STARVIS 2 IMX335 sensor with F/1.55 aperture, 142° ultra-wide angle lens, 4K (interpolated) video, HDR/WDR support, IP66 waterproofing, and 1800mAh battery for up to 4.5 hours of recording.

AKY-710Lite  |  Lightweight Entry Model  |  US$79.99
Weighing just 101g, the 710Lite delivers 2K recording at 28fps, F/2.0 aperture, 120° wide angle, IP66 waterproofing, and an impressive 7.5-hour battery life. Ideal for budget-conscious cyclists.

Why AKEEYO

Premium Sony & GC8613 sensors for exceptional image quality in all lighting conditionsIP66–IP67 waterproof and dustproof ratings for reliable performance in any weatherEIS electronic image stabilization for smooth, shake-free footage on the road

“Cycle Mode Tokyo 2026 is a landmark opportunity for AKEEYO to connect directly with Japan’s passionate riding community. We invite every cyclist and motorcyclist to visit our booth, test our cameras in person.”
— AKEEYO Marketing Team

Distributor & Dealer Opportunities

AKEEYO is actively seeking distributors and dealers worldwide. Visit our booth or reach out via the contact details below.

Website

www.akeeyo.com

Dealer Application

Application Form

About AKEEYO

AKEEYO specializes in smart recording solutions for motorcycles, bicycles, and vehicles — from pro-grade action cameras to intelligent dash cam systems. The brand serves markets across Asia, Europe, and the Americas through its global distributor network and e-commerce channels.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/akeeyo-to-showcase-710–730-series-cycling-cameras-at-cycle-mode-tokyo-2026-302750360.html

SOURCE AKEEYO

Continue Reading

Trending